nach oben

Erschienen in:

17.04.2024 | SAGES/EAES Official Publication

TAVAC: comprehensive review of currently available hemostatic products as adjunct to surgical hemostasis

verfasst von: Iswanto Sucandy, Sharona Ross, Jonathan DeLong, Michael Tran, Fred Qafiti, David Pechman, Tim Snow, Salvatore Docimo, Allyson Lim-Dy, Maria Christodoulou, David Renton

Erschienen in: Surgical Endoscopy | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

The use of hemostatic agents by general surgeons during abdominal operations is commonplace as an adjunctive measure to minimize risks of postoperative bleeding and its downstream complications. Proper selection of products can be hampered by marginal understanding of their pharmacokinetics and pharmacodynamics. While a variety of hemostatic agents are currently available on the market, the choice of those products is often confusing for surgeons. This paper aims to summarize and compare the available hemostatic products for each clinical indication and to ultimately better guide surgeons in the selection and proper use of hemostatic agents in daily clinical practice.

Methods

We utilized PubMed electronic database and published product information from the respective pharmaceutical companies to collect information on the characteristics of the hemostatic products.

Results

All commercially available hemostatic agents in the US are described with a description of their mechanism of action, indications, contraindications, circumstances in which they are best utilized, and expected results.

Conclusion

Hemostatic products come with many different types and specifications. They are valuable tools to serve as an adjunct to surgical hemostasis. Proper education and knowledge of their characteristics are important for the selection of the right agent and optimal utilization.

Ghadimi K, Levy JH, Welsby IJ (2016) Perioperative management of the bleeding patient. Br J Anaesth 117:iii18–iii30. https://doi.org/10.1093/bja/aew358CrossRefPubMedPubMedCentral

Price JS, Tackett S, Patel V (2015) Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery. J Med Econ 18(10):777–786. https://doi.org/10.3111/13696998.2015.1046879. Erratum in: J Med Econ. 2016, 19(3):315–7. PMID: 25934148

Ramirez Manuel G, Castillo George F, Ramirez MA (2019) The economic burden of bleeds and transfusions in selected surgeries: a retrospective multi center analysis from the US perspective. Am J Biomed Sci Res 2(5):211–216. https://doi.org/10.34297/AJBSR.2019.02.000610CrossRef

Hughes MJ, Ventham NT, Harrison EM, Wigmore SJ (2015) Central venous pressure and liver resection: a systematic review and meta-analysis. HPB (Oxford) 17(10):863–871. https://doi.org/10.1111/hpb.12462CrossRefPubMed

Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Triulzi D, Doree C, Hebert PC. (2016) Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev (10):CD002042. https://doi.org/10.1002/14651858.CD002042.pub4. Update in: Cochrane Database Syst Rev. 2021, (12):CD002042. PMID: 27731885; PMCID: PMC6457993

Connor JP, Destrampe E, Robbins D, Hess AS, McCarthy D, Maloney J (2023) Pre-operative anemia and peri-operative transfusion are associated with poor oncologic outcomes in cancers of the esophagus: potential impact of patient blood management on cancer outcomes. BMC Cancer 23(1):99. https://doi.org/10.1186/s12885-023-10579-xCrossRefPubMedPubMedCentral

Seong H, Jang Y, Ko E, Lee J, Kim T, Lim CH, Shin HJ, Kim YH, Kim DS (2023) Impact of preoperative red blood cell transfusion on long-term mortality of liver transplantation: a retrospective cohort study. Medicine (Baltimore) 102(37):e34914. https://doi.org/10.1097/MD.0000000000034914CrossRefPubMed

Brown KGM, Solomon MJ (2024) Topical haemostatic agents in surgery. Br J Surg 111(1):znad361. https://doi.org/10.1093/bjs/znad361CrossRefPubMed

Tam T, Harkins G, Dykes T, Gockley A, Davies M (2014) Oxidized regenerated cellulose resembling vaginal cuff abscess. JSLS. 18(2):353–356. https://doi.org/10.4293/108680813X13693422518597CrossRefPubMedPubMedCentral

10.

Zhou Y, Ma X, Li Z, Wang B (2021) Efficacy, safety, and physicochemical properties of a flowable hemostatic agent made from absorbable gelatin sponge via vacuum pressure steam sterilization. J Biomater Appl 35(7):776–789. https://doi.org/10.1177/0885328220950899CrossRefPubMed

11.

Danker Iii W, DeAnglis A, Ferko N, Garcia D, Hogan A (2020) Comparison of fibrin sealants in peripheral vascular surgery: a systematic review and network meta-analysis. Ann Med Surg (Lond) 9(61):161–168. https://doi.org/10.1016/j.amsu.2020.12.003CrossRef

12.

Corral M, Ferko N, Hogan A, Hollmann SS, Gangoli G, Jamous N, Batiller J, Kocharian R (2016) A hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding. Clinicoecon Outcomes Res 21(8):507–519. https://doi.org/10.2147/CEOR.S112762.PMID:27703386;PMCID:PMC5036832CrossRef

13.

Koea J, Baldwin P, Shen J, et al. (2015) Safety and hemostatic effectiveness of the fibrin pad for severe soft-tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic (non-cardiac) surgery: a randomized, controlled, superiority trial. World J Surg 39(11):2663-9. https://doi.org/10.1007/s00268-015-3106-5. Erratum in: World J Surg 2015, 39(10):2610. PMID: 26041587

14.

Koea JB, Batiller J, Aguirre N et al (2016) A multicentre, prospective, randomized, controlled trial comparing EVARREST™ fibrin sealant patch to standard of care in controlling bleeding following elective hepatectomy: anatomic versus non-anatomic resection. HPB (Oxford) 18(3):221–228. https://doi.org/10.1016/j.hpb.2015.12.006CrossRefPubMed

15.

Assessment of the hemostatic efficacy of PERCLOT, Surgicel Powder, and Arista in a porcine liver abrasion model. December 2021. Baxter Data on File. REF-36820.

16.

Water Mass Absorbance: PERCLOT versus Arista. August 2014. Baxter Data on File. REF-32407.

17.

Evaluation of the adhesive properties of PERCLOT and Arista. September 2022. Baxter Data on File. REF-37550.

18.

Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH (2001) Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 233(1):88–96. https://doi.org/10.1097/00000658-200101000-00014CrossRefPubMedPubMedCentral

19.

Lew WK, Weaver FA (2008) Clinical use of topical thrombin as a surgical hemostat. Biologics 2(4):593–599. https://doi.org/10.2147/btt.s2435CrossRefPubMedPubMedCentral

20.

Baxter Healthcare. FLOSEAL with RECOTHROM instructions for use.

21.

Baxter Healthcare. Data on File.

22.

Stokes ME et al (2011) Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res 11:135CrossRefPubMedPubMedCentral

23.

Baxter Healthcare (n.d.) TISSEEL [fibrin sealant] full prescribing information. http://baxterpi.com/pi-pdf/Tisseel_PI.pdf

24.

Baxter Data on File. REF-27773.

25.

Maisano F, Kjaergård HK, Bauernschmitt R, Pavie A, Rábago G, Laskar M, Marstein JP, Falk V (2009) TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial. Eur J Cardio-Thorac Surg: Off J Eur Assoc Cardio-Thorac Surg 36(4):708–714. https://doi.org/10.1016/j.ejcts.2009.04.057CrossRef

26.

Genyk Y, Kato T, Pomposelli JJ, Wright JK, Sher LS, Tetens V, Chapman WC (2016) Fibrin sealant patch (TachoSil) vs oxidized Regenerated cellulose patch (surgicel original) for the secondary treatment of local bleeding in patients undergoing hepatic resection: a randomized controlled trial. J Am Coll Surg 222(3):261–268. https://doi.org/10.1016/j.jamcollsurg.2015.12.007CrossRefPubMed

27.

Baxter Health (n.d.) ARTISS [Fibrin sealant (human)] full prescribing information: http://baxterpi.com/pi-pdf/Artiss_PI.pdf

28.

Spotnitz WD (2014) Fibrin sealant: the only approved hemostat, sealant, and adhesive-a laboratory and clinical perspective. ISRN Surg 4:203943. https://doi.org/10.1155/2014/203943.CrossRef

29.

Foster K, Greenhalgh D, Gamelli RL et al (2008) FS 4IU VH S/D clinical study group. Efficacy and safety of a fibrin sealant for adherence of autologous skin grafts to burn wounds: results of a phase 3 clinical study. J Burn Care Res 29(2):293–303. https://doi.org/10.1097/BCR.0b013e31816673f8CrossRefPubMed

30.

HesterShire TRJR, Nguyen DB, Gerut ZE et al (2013) Randomized, controlled, phase 3 study to evaluate the safety and efficacy of fibrin sealant VH S/D 4 s-apr (Artiss) to improve tissue adherence in subjects undergoing rhytidectomy. Aesthet Surg J 33(4):487–496. https://doi.org/10.1177/1090820X13479969CrossRef

31.

Baxter Healthcare Corporation (2009) COSEAL surgical sealant instructions for use. Hayward, CA

32.

Hill A, Estridge TD, Maroney M et al (2001) Treatment of suture line bleeding with a novel synthetic surgical sealant in a canine iliac PTFE graft model. J Biomed 58:308–312

33.

Wallace DG, Cruise GM, Rhee WM et al (2001) A tissue sealant based on reactive multifunctional polyethylene glycol. J Biomed 58:545–555

34.

Natour E, Suedkamp M, Dapunt OE (2012) Assessment on the effect of blood loss and transfusion requirements when adding a polyethylene glycol sealant to the anastomotic closure of aortic procedures: a case-control analysis of 102 patients undergoing Bentall procedures. J Cardiothorac Surg 7:105CrossRefPubMedPubMedCentral

35.

Hagberg RC, Safi HJ, Sabik J et al (2004) Improved intraoperative management of anastomotic bleeding during aortic reconstruction: results of a randomized controlled trial. Am Surg 70:307–311CrossRefPubMed

36.

Florek H-J, Brunkwall J, Orend K-H, Handley I, Pribble J, Dieck R (2015) Results from a first-in-human trial of a novel vascular sealant. Front Surg 2:29. https://doi.org/10.3389/fsurg.2015.00029CrossRefPubMedPubMedCentral

37.

Stone WM, Cull DL, Money SR (2012) A randomized prospective multicenter trial of a novel vascular sealant. Ann Vasc Surg 26(8):1077–1084CrossRefPubMed

38.

Tenaxis Medical, Inc. (2013) Clinical evaluation report for ArterX surgical sealant

39.

Tenaxis Medical, Inc. (2013) Summary of safety and effectiveness: ArterX surgical sealant

40.

Chapman WC, Singla N, Genyk Y et al (2007) A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surg 205(2):256–265CrossRefPubMed

41.

Bracey A, Shander A, Aronson S et al (2017) The use of topical hemostatic agents in cardiothoracic surgery. Ann Thorac Surg 105:353–360CrossRef

42.

CryoLife (2001) Summary of safety and effectiveness CryoLife, Inc., BioGlue surgical adhesive. https://www.accessdata.fda.gov/cdrh_docs/pdf/p010003b.pdf. Accessed 15 July 2023

43.

Artivon (n.d.) BioGlue® Surgical Adhesive–Artivion. https://artivion.com/product/bioglue/. Accessed 15 July 2023

44.

Hoffmann NE, Siddiqui SA, Agarwal S et al (2009) Choice of hemostatic agent influences adhesion formation in a rat cecal adhesion model. J Surg Res 155(1):77–81. https://doi.org/10.1016/j.jss.2008.08.008CrossRefPubMed

45.

Cziperle DJ (2021) Avitene™ Microfibrillar Collagen Hemostat for adjunctive hemostasis in surgical procedures: a systematic literature review. Med Devices (Auckl) 1(14):155–163. https://doi.org/10.2147/MDER.S298207.PMID:34104007;PMCID:PMC8179802CrossRef

46.

Council on Pharmacy and Chemistry (1947) Absorbable gelatin sponge— new and nonofficial remedies. JAMA 135:921

47.

Doria C, Fischer CP, Wood CG, Lifg PM, Marra S, Hart J (2008) Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery. Curr Med Res Opin 24(3):785–794CrossRefPubMed

48.

ClinicalTrials.gov (2007) Evaluation of an absorbable surgical hemostatic agent: Thrombi-Gel® versus Gelfoam-thrombin (control). NCT00652314. https://clinicaltrials.gov/ct2/show/NCT00652314. Accessed 11 Jan, 2023.

49.

Hafer A, Verga J, Sulava E et al (2023) The evaluation of Hemoblast Bellows for arterial hemorrhage control in a swine model of vascular injury. Trauma. https://doi.org/10.1177/14604086231152670CrossRef

Titel: TAVAC: comprehensive review of currently available hemostatic products as adjunct to surgical hemostasis
verfasst von: Iswanto Sucandy
Sharona Ross
Jonathan DeLong
Michael Tran
Fred Qafiti
David Pechman
Tim Snow
Salvatore Docimo
Allyson Lim-Dy
Maria Christodoulou
David Renton
Publikationsdatum: 17.04.2024
Verlag: Springer US
Erschienen in: Surgical Endoscopy / Ausgabe 5/2024
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI: https://doi.org/10.1007/s00464-024-10806-x

Neu im Fachgebiet Chirurgie

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2024

Large language models and bariatric surgery patient education: a comparative readability analysis of GPT-3.5, GPT-4, Bard, and online institutional resources

Preoperative comorbidities as a predictor of EBWL after bariatric surgery: a retrospective cohort study

Trends in minimally invasive and open inguinal hernia repair: an analysis of ACGME general surgery case logs

Impact on carotid intima-media thickness after laparoscopic sleeve gastrectomy in patients with morbid obesity

Enhancing endoscopic measurement: validating a quantitative method for polyp size and location estimation in upper gastrointestinal endoscopy

Commentary on the index admission cholecystectomy for acute cholecystitis reduces 30-day readmission rates in pediatric patients

Update Chirurgie